Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Lepu Bio
company
About
Lepu Bio is a Innovation-Driven Biopharmaceutical Company.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥1.29B
- Industries
- Biotechnology,Health Care,Medical,Service Industry,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥2.19B
Lepu Bio has raised a total of
¥2.19B
in funding over 2 rounds. Their latest funding was raised on
Aug 6, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 6, 2020 | Series B | ¥1.29B | 2 | — | — | Detail |
| Jul 2, 2019 | Series A | ¥0.90B | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Lepu Bio is funded by 3 investors.
State New Central Enterprises Operating Investment Fund
and Haitong Innovation Capital Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
